Butane Hash Oil Burns: A 7-Year Perspective on a Growing Problem

Journal of Burn Care and Research

Volumn 38, Issue 1, 2017, Pages e165-e171

  Romanowski, Kathleen S ^a,b   Barsun, Alura ^a,b   Kwan, Peter ^a,b   Teo, Esther H ^a,b   Palmieri, Tina L ^a,b   Sen, Soman ^a,b   Maguina, Pirko ^a,b   Greenhalgh, David G ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTANE; BUTANE HASH OIL; CANNABIS; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; MEDICAL CANNABIS; VEGETABLE OIL;

ADOLESCENT; ADULT; ARTICLE; CANNABIS USE; CHEMICAL BURN; CHILD; DEMOGRAPHY; DISTILLATION; FEMALE; HUMAN; LENGTH OF STAY; LUNG BURN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; VENTILATOR; COHORT ANALYSIS; INCIDENCE; INJURY SCALE; NEEDS ASSESSMENT; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK ASSESSMENT; SUPPLY AND DISTRIBUTION; UNITED STATES; YOUNG ADULT;

ADULT; BURNS, CHEMICAL; BURNS, INHALATION; BUTANES; CANNABIS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INJURY SEVERITY SCORE; MALE; MEDICAL MARIJUANA; NEEDS ASSESSMENT; PLANT OILS; PUBLIC HEALTH; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 84964037913     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0000000000000334     Document Type: Article

References (46)

1. Fitzwater J, Purdue GF, Hunt JL, O'Keefe GE. The risk factors and time course of sepsis and organ dysfunction after burn trauma. J Trauma 2003;54:959-66
2. Sharma BR, Harish D, Singh VP et al. Septicemia as a cause of death in burns: an autopsy study. Burns 2006;32:545-9
3. D'Avignon LC, Hogan BK, Murray CK, et al. Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: an autopsy series. Burns 2010;36:773-9
4. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis 2003;37:543-50
5. Appelgren P, Björnhagen V, Bragderyd K et al. A prospective study of infections in burn patients. Burns 2002;28:39-46
6. Santucci SG, Gobara S, Santos CR et al. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect 2003;53:6-13
7. Kamolz LP. Burns: learning from the past in order to be fit for the future. Crit Care 2010;14:106
8. Murray CK, Loo FL, Hospenthal DR, et al. Incidence of systemic fungal infection and related mortality following severe burns. Burns 2008;34:1108-12
9. Cohen J, Brun-Buisson C, Torres A et al. Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 2004;32(11 Suppl):S466-94
10. Greenhalgh DG, Saffle JR, Holmes JH 4th, et al.; American Burn Association Consensus Conference on Burn Sepsis and Infection Group. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007;28:776-90
11. Lavrentieva A, Kontakiotis T, Lazaridis L, et al. Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? Burns 2007;33:189-94
12. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96
13. Ferrer R, Artigas A, Suarez D, et al.; Edusepsis Study Group. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009;180:861-6
14. Dellinger RP, Levy MM, Rhodes A, et al.; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228
15. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014;40:1795-815
16. Hernandez G, Castro R, Romero C, et al. Persistent sepsisinduced hypotension without hyperlactatemia: is it really septic shock? J Crit Care 2011;26:435.e9-14
17. Wacharasint P, Nakada TA, Boyd JH et al. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock 2012;38:4-10
18. Howell MD, Donnino M, Clardy P et al. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 2007;33:1892-9
19. Mustonen KM, Vuola J. Acute renal failure in intensive care burn patients. J Burn Care Res 2008;29:227-37
20. Palmieri T, Lavrentieva A, Greenhalgh DG. Acute kidney injury in critically ill burn patients. Risk factors, progression and impact on mortality. Burns 2010;36:205-11
21. Stewart IJ, Tilley MA, Cotant CL et al. Association of AKI wAden JKith adverse outcomes in burned military casualties. Clin J Am Soc Nephrol 2012;7:199-206
22. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81
23. Cillóniz C, Ewig S, Ferrer M, et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care 2011;15:R209
24. Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care 2013;17:204
25. Annane D, Aegerter P, Jars-Guincestre MC et al. CUBRéa Network. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med 2003;168:165-72
26. Finfer S, Bellomo R, Lipman J et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004;30:589-96
27. Quenot JP, Binquet C, Kara F, et al. The epidemiology of septic shock in French itensive care units: the prospective multicenter cohort EPISS study. Crit Care 2013;17:R65
28. Schlapbach LJ, Straney L, Alexander J, et al.; ANZICS Paediatric Study Group. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis 2015;15:46-54
29. Church D, Elsayed S, Reid O et al. Burn wound infections. Clin Microbiol Rev 2006;19:403-34
30. Ravat F, Le-Floch R, Vinsonneau C, et al.; Société Française d'Etude et de Traitement des Brûlures (SFETB). Antibiotics and the burn patient. Burns 2011;37:16-26
31. Mann-Salinas EA, Baun MM, Meininger JC, et al. Novel predictors of sepsis outperform the American Burn Association sepsis criteria in the burn intensive care unit patient. J Burn Care Res 2013;34:31-43
32. Hogan BK, Wolf SE, Hospenthal DR, et al. Correlation of American Burn Association sepsis criteria with the presence of bacteremia in burned patients admitted to the intensive care unit. J Burn Care Res 2012;33:371-8
33. Marck RE, Montagne HL, Tuinebreijer WE et al. Time course of thrombocytes in burn patients and its predictive value for outcome. Burns 2013;39:714-22
34. Shorr AF, Micek ST, Jackson WL Jr et al. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med 2007;35:1257-62
35. Trzeciak S, Dellinger RP, Abate NL, et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006;129:225-32
36. Kumar A, Safdar N, Kethireddy S, Chateau D. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study. Crit Care Med 2010;38:1651-64
37. Micek ST, Welch EC, Khan J, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 2010;54:1742-8
38. Niederman MS, Soulountsi V. De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia? Clin Chest Med 2011;32:517-34
39. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 2014;40:32-40
40. Sligl WI, Milner DA Jr, Sundar S et al. Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis. Clin Infect Dis 2009;49:93-101
41. Patel GP, Balk RA. Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 2012;185:133-9
42. Marecaux G, Pinsky MR, Dupont E et al. Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med 1996;22:404-8
43. Cochran A, Edelman LS, Saffle JR et al. The relationship of serum lactate and base deficit in burn patients to mortality. J Burn Care Res 2007;28:231-40
44. Jeng JC, Jablonski K, Bridgeman A et al. Serum lactate, not base deficit, rapidly predicts survival after major burns. Burns 2002;28:161-6
45. Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 2015;43:567-73
46. Brusselaers N, Monstrey S, Colpaert K et al. Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis. Intensive Care Med 2010;36:915-25